Résultats de la recherche - 146 results
SARS-CoV-2 seroprevalence and determinants for salivary seropositivity among pupils and school staff: a prospective cohort study
also in October and December 2021 for primary pupils. We recruited 885 primary and 569 secondary pupils and 799 staff in 84 schools. Cumulative seroprevalence (95% CI) among primary pupils increased from ...
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 framework.
confidence interval [CI]: 0.99-1.03) and 1.02 (95% CI: 1.0-1.04), respectively. Noninferiority p values were all ≤0.05, except for CIN3 + in patients ≥30 years. Excellent intra- and interlaboratory ...
Inequalities in mortality associated with housing conditions in Belgium between 1991 and 2020
housing inequality. RESULTS: Up to 18.5% (95% CI 17.7-19.3) of all deaths between 1991 and 2020 may be associated with housing inequality, corresponding to 584,875 deaths. Over time, life expectancy at birth increased ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
non-inferior to the full dose if the lower limit of the two-sided 95% CI of the GMR was >0.67. Primary analysis was done on the per-protocol population, including infection naïve participants only. 145 ...
Offering HPV self-sampling kits: an updated meta-analysis of the effectiveness of strategies to increase participation in cervical cancer screening
compared to controls. Pooled participation difference (PD) and 95% confidence interval (CI) for experimental vs. control was 13.2% (95% CI = 11.0–15.3%) for mail-to-all, 4.4% (95% CI = 1.2–7.6%) for ...
Immunogenicity and one-year boostability of a 3-dose intramuscular rabies pre-exposure prophylaxis schedule in adults receiving immunosuppressive monotherapy: a prospective single-Centre clinical trial.
primary endpoint. RESULTS: We included 56 individuals, of whom 52 completed the study. The one-year boostability was 90% (47/52) with a GMT of 6.16 (95% CI 3.83-9.91). All participants seroconverted at some point in ...
Impact of COVID-19 on the Belgian HIV epidemic: slowdown of HIV transmission and testing and adaptation of care.
HIV infections decreased by 47.1% in 2020 (n = 27) compared to 2019 (n = 51). Late HIV diagnoses decreased by 24.7% (95% CI [- 40.7%;-9.7%]) in 2020 compared to 2019. Of patients in care in 2019, 11.8% ...
Surveillance épidémiologique des infections invasives à Haemophilus influenzae – 2019 à 2021
d’H.influenzae recueillies par le CNR étaient non-typables. Celles-ci représentaient 79,0% des souches en 2019, 73,8 % en 2020 et 78,0% en 2021. · Dix décès ont été signalés au CNR en 2019 (1 lié au sérotype ...
Estimates of people who injected drugs within the last 12 months in Belgium- presentation
model, we reached an estimated total population of adult PWID in Brussels of 703 (95 % CI 538–935), which means an estimated population prevalence of 0.8 PWID per 1000 adult inhabitants (95 % CI 0.6–1.0) ...
Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.
heterologous boosted subjects (GMT 1755.90 BAU /mL [95% CI 1276.95-2414.48] vs 1495.82 BAU /mL (95% CI 1131.48-1977.46)). However, homologous boosted subjects show significantly higher NT50 values against BA.1 ...